Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 24.24 USD 0.08% Market Closed
Updated: May 19, 2024

Castle Biosciences Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Castle Biosciences Inc
Operating Income Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Castle Biosciences Inc
NASDAQ:CSTL
Operating Income
-$41.9m
CAGR 3-Years
-47%
CAGR 5-Years
-108%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Operating Income
$1.7B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Quest Diagnostics Inc
NYSE:DGX
Operating Income
$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
1%
CAGR 10-Years
2%
CVS Health Corp
NYSE:CVS
Operating Income
$13.6B
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
5%
Cigna Corp
NYSE:CI
Operating Income
$9.3B
CAGR 3-Years
3%
CAGR 5-Years
13%
CAGR 10-Years
12%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Income
$1.1B
CAGR 3-Years
-34%
CAGR 5-Years
-5%
CAGR 10-Years
2%

See Also

What is Castle Biosciences Inc's Operating Income?
Operating Income
-41.9m USD

Based on the financial report for Mar 31, 2024, Castle Biosciences Inc's Operating Income amounts to -41.9m USD.

What is Castle Biosciences Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-108%

Over the last year, the Operating Income growth was 58%. The average annual Operating Income growth rates for Castle Biosciences Inc have been -47% over the past three years , -108% over the past five years .